CORRESPONDENCE / EDITORIAL ONLY
Reach the editors of the record.
For corrections, citation queries, and editorial correspondence about the CJC-1295 dossier.
Editorial correspondence
This is the contact surface for Safe CJC-1295, a public-record dossier on the published CJC-1295 research. Use the form for corrections, citation queries, or questions about how a finding is summarized. If you believe a study is mischaracterized or a citation is wrong, send the study and it will be checked against the page.
Only editorial correspondence can be answered here. The dossier keeps no consulting room and no stockroom: it offers no medical advice, sells or supplies no compound, and cannot recommend doses, sources, or treatment. Inquiries about purchasing, prescribing, or administering CJC-1295 fall outside what it does, because the site does none of those things [8].
What this form is not for
Please do not use this form to request medical guidance, a prescription, a supplier, or a dosing protocol. CJC-1295 is an unapproved research chemical with no validated human use [8], and we have no clinical staff to advise on it. Questions of that kind are outside what an editorial publisher can or should answer.
For the substance of the record, the pages answer most questions directly: the safety reading, the DAC vs no-DAC distinction, the doses used in the studies, and the full reference list with every source.